ダウンロード数: 609
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
35_737.pdf | 767.39 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 大村, 清隆 | ja |
dc.contributor.author | 塚本, 泰司 | ja |
dc.contributor.alternative | Ohmura, Kiyotaka | en |
dc.contributor.alternative | Tsukamoto, Taiji | en |
dc.date.accessioned | 2010-06-01T01:58:46Z | - |
dc.date.available | 2010-06-01T01:58:46Z | - |
dc.date.issued | 1989-05 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/116545 | - |
dc.description.abstract | Clonogenic assayを用いて, 腎細胞癌に対するインターフェロン(IFN)の抗腫瘍効果を検討した所, 濃度依存性がみられ, 手術時採取した標本15例に就て, コロニー形成率が低下する群(10例)と, 高濃度でもコロニー形成率の低下しない群(5例)がみられた.rIFN-αA 1, 000 IU/ml濃度での15例の感受性は3例に止まった.IFNの抗腫瘍効果には限界があり, 株化腎細胞癌, 株化培養細胞を用いての制癌剤併用効果は, VBL, ADM, MTX, 5-FU何れとも効果があった | ja |
dc.description.abstract | With human tumor clonogenic assay, the direct antiproliferative activity of recombinant human leukocyte interferon alpha (IFN-alpha) was investigated on human renal cell carcinomas (RCCs), which consisted of a human RCC cell line (ACHN), two human RCC xenografts and fifteen primary RCCs. The combination effect of IFN-alpha with a cancer chemotherapeutic agent was studied, as well, with the assay system. IFN-alpha showed a dose-dependent antiproliferative activity against the human RCCs. The clonal growth of ACHN cell line was inhibited by less than 50% at the concentration of 1, 000 IU/ml. Two xenografts had a different sensitivity to IFN-alpha, in which the percent colony formation was less than 20% in RCC-3 at the concentration of 100-100, 000 IU/ml, while in RCC-4 more than 50% even at the high concentration of 10, 000 IU/ml. In 15 primary tumors obtained at surgery, two types of response to IFN-alpha were demonstrated. One was the response in which the colony formation was inhibited in a dose-dependent manner as an increment of IFN-alpha concentration, and the other in which the colony formation was not sufficiently inhibited even at the high concentration of IFN-alpha. The dose-dependent inhibition of colony formation was demonstrated in 10 out of 15 specimens (66.7%). When the colony formation suppressed to less than 50% of control was considered to be sensitive to IFN-alpha, 6.7% of these 15 primary tumors were sensitive to IFN-alpha at 100 IU/ml, 20.0% at 1, 000 IU/ml and 20.0% at 10, 000 IU/ml. Combination effects of IFN-alpha and with each of four different cancer chemotherapeutic agents (vinblastine, adriamycin, methotrexate, 5-fluorouracil) were investigated on the ACHN cell line. Every combination type produced a subadditive or synergistic combination effect. In particular, the combination of IFN-alpha with vinblastine of more than 0.1 microgram/ml concentration yielded a combination effect of statistical significance (p less than 0.001). Even against premary tumors, the combination of IFN-alpha with vinblastine showed a synergistic effect in one out of every three tumors. These results suggested that the combination of IFN-alpha with a cancer chemotherapeutic agent would enhance the clinical effect of IFN-alpha alone in only a certain situation. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Antineoplastic Agents/administration & dosage | en |
dc.subject | Antineoplastic Combined Chemotherapy Protocols/pharmacology | en |
dc.subject | Carcinoma, Renal Cell/pathology | en |
dc.subject | Cell Division/drug effects | en |
dc.subject | Dose-Response Relationship, Drug | en |
dc.subject | Drug Synergism | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Interferon Type I, Recombinant/administration & dosage/pharmacology | en |
dc.subject | Kidney Neoplasms/pathology | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Tumor Cells, Cultured/drug effects/pathology | en |
dc.subject | Tumor Stem Cell Assay | en |
dc.subject.ndc | 494.9 | - |
dc.title | Clonogenic assayを用いた腎細胞癌に対するインターフェロンの抗腫瘍効果の検討 --単独ならびに制癌剤との併用効果について-- | ja |
dc.title.alternative | Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 35 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 737 | - |
dc.identifier.epage | 747 | - |
dc.textversion | publisher | - |
dc.sortkey | 01 | - |
dc.address | 札幌医科大学泌尿器科学教室 | ja |
dc.address.alternative | The Department of Urology, Sapporo Medical College | en |
dc.identifier.pmid | 2801371 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.35 No.5 |
![](/dspace/image/articlelinker.gif)
このリポジトリに保管されているアイテムはすべて著作権により保護されています。